Patents by Inventor Peter Faarup

Peter Faarup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050101573
    Abstract: Certain novel sterol derivatives can be used for regulating the meiosis in oocytes and in male germ cells.
    Type: Application
    Filed: December 16, 2004
    Publication date: May 12, 2005
    Applicants: Novo Nordisk A/S, Schering AG
    Inventors: Peter Faarup, Frederick Gronvald, Thorsten Blume, Anthony Murray, Jens Breinholt
  • Patent number: 6884796
    Abstract: Certain novel sterol derivatives can be used for regulating the meiosis in oocytes and in male germ cells.
    Type: Grant
    Filed: June 4, 2002
    Date of Patent: April 26, 2005
    Assignees: NovoNordisk A/S, Schering AG
    Inventors: Peter Faarup, Frederick Christian Grønvald, Thorsten Blume, Anthony Murray, Jens Breinholt
  • Publication number: 20050004382
    Abstract: Certain compounds, structurally related to natural compounds which can be extracted i.a. from bull testes and from human follicular fluid, can be used for regulating the meiosis in oocytes and in male germ cells. Some of these compounds are useful in the treatment of infertility, whereas other compounds are useful as contraceptives. These compounds have the structural formula wherein the substituents are as defined in the specification.
    Type: Application
    Filed: May 11, 2004
    Publication date: January 6, 2005
    Inventors: Christian Grondahl, Frederik Gronvald, Peter Faarup, Anthony Murray, Jan Ottesen
  • Patent number: 6759400
    Abstract: Certain compounds, structurally related to natural compounds which can be extracted i.a. from bull testes and from human follicular fluid, can be used for regulating the meiosis in oocytes and in male germ cells. Some of these compounds are useful in the treatment of infertility, whereas other compounds are useful as contraceptives. These compounds have the structural formula wherein the substituents are as defined in the specification.
    Type: Grant
    Filed: September 11, 2002
    Date of Patent: July 6, 2004
    Assignee: Novo Nordisk A/S
    Inventors: Christian Grondahl, Frederik Christian Gronvald, Peter Faarup, Anthony Murray, Jan Lund Ottesen
  • Publication number: 20040048838
    Abstract: Sterol derivative compounds, structurally related to natural compounds which can be extracted from bull testes and from human follicular fluid, useful for regulating meiosis in oocytes and in male germ cells. Some of these compounds are useful in the treatment of infertility, whereas other compounds are useful as contraceptives.
    Type: Application
    Filed: September 9, 2003
    Publication date: March 11, 2004
    Inventors: Frederik Christian Gronvald, Peter Faarup, Erling Guddal
  • Patent number: 6653492
    Abstract: Certain bile acids find use in the pharmaceutical industry. In view of the wide distribution of serious diseases such as HIV, AIDS and Bovine Spongiform Encephalopathy (BSE) it is desirable to avoid—as far as practicable—to have any components of animal origin in medicaments in order to eliminate any danger of infection. The present invention relates to a method of providing bile acids from non-animal starting materials.
    Type: Grant
    Filed: May 1, 2002
    Date of Patent: November 25, 2003
    Assignee: Novo Nordick A/S
    Inventor: Peter Faarup
  • Patent number: 6645953
    Abstract: Sterol derivative compounds, structurally related to natural compounds which can be extracted from bull testes and from human follicular fluid, useful for regulating meiosis in oocytes and in male germ cells. Some of these compounds are useful in the treatment of infertility, whereas other compounds are useful as contraceptives.
    Type: Grant
    Filed: June 11, 2001
    Date of Patent: November 11, 2003
    Assignee: Novo Nordisk A/S
    Inventors: Frederik Christian Gronvald, Peter Faarup, Erling Guddal
  • Publication number: 20030032824
    Abstract: Certain compounds, structurally related to natural compounds which can be extracted i.a. from bull testes and from human follicular fluid, can be used for regulating the meiosis in oocytes and in male germ cells. Some of these compounds are useful in the treatment of infertility, whereas other compounds are useful as contraceptives.
    Type: Application
    Filed: September 11, 2002
    Publication date: February 13, 2003
    Inventors: Christian Grondahl, Frederik Christian Gronvald, Peter Faarup, Anthony Murray, Jan Lund Ottesen
  • Publication number: 20020183283
    Abstract: Certain novel sterol derivatives can be used for regulating the meiosis in oocytes and in male germ cells.
    Type: Application
    Filed: June 4, 2002
    Publication date: December 5, 2002
    Inventors: Peter Faarup, Frederick Christian Gronvald, Thorsten Blume, Anthony Murray, Jens Breinholt
  • Publication number: 20020183531
    Abstract: Certain bile acids find use in the pharmaceutical industry. In view of the wide distribution of serious diseases such as HIV, AIDS and Bovine Spongiform Encephalopathy (BSE) it is desirable to avoid—as far as practicable—to have any components of animal origin in medicaments in order to eliminate any danger of infection. The present invention relates to a method of providing bile acids from non-animal starting materials.
    Type: Application
    Filed: May 1, 2002
    Publication date: December 5, 2002
    Inventor: Peter Faarup
  • Patent number: 6486145
    Abstract: Certain compounds, structurally related to natural compounds which can be extracted i.a. from bull testes and from human follicular fluid, can be used for regulating the meiosis in oocytes and in male germ cells. Some of these compounds are useful in the treatment of infertility, whereas other compounds are useful as contraceptives. These compounds have the structural formula wherein the substituents are as defined in the specification.
    Type: Grant
    Filed: January 17, 2001
    Date of Patent: November 26, 2002
    Assignee: Novo Nordisk A/S
    Inventors: Christian Grondahl, Frederik Christian Gronvald, Peter Faarup, Anthony Murray, Jan Lund Ottesen
  • Patent number: 6407086
    Abstract: Certain novel sterol derivatives can be used for regulating the meiosis in oocytes and in male germ cells.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: June 18, 2002
    Assignees: Novo Nordisk A/S, Schering Aktiengesellschaft
    Inventors: Peter Faarup, Frederick Christian Grønvald, Thorsten Blume, Anthony Murray, Jens Breinholt
  • Publication number: 20020013302
    Abstract: Sterol derivative compounds, structurally related to natural compounds which can be extracted from bull testes and from human follicular fluid, useful for regulating meiosis in oocytes and in male germ cells. Some of these compounds are useful in the treatment of infertility, whereas other compounds are useful as contraceptives.
    Type: Application
    Filed: June 11, 2001
    Publication date: January 31, 2002
    Inventors: Frederick Christian Gronvald, Peter Faarup, Erling Guddal
  • Publication number: 20020007079
    Abstract: Certain novel sterol derivatives having no hydroxy group in the 3-position can be used to regulate the meiosis in oocytes and in male germ cells. Some of these compounds are useful in the treatment of infertility, whereas other compounds are useful as contraceptives.
    Type: Application
    Filed: July 9, 1999
    Publication date: January 17, 2002
    Inventors: ANTHONY MURRAY, PETER FAARUP
  • Publication number: 20010005757
    Abstract: Certain compounds, structurally related to natural compounds which can be extracted i.a. from bull testes and from human follicular fluid, can be used for regulating the meiosis in oocytes and in male germ cells. Some of these compounds are useful in the treatment of infertility, whereas other compounds are useful as contraceptives.
    Type: Application
    Filed: January 17, 2001
    Publication date: June 28, 2001
    Inventors: Christian Grondahl, Frederik Christian Gronvald, Peter Faarup, Anthony Murray, Jan Lund Ottesen
  • Publication number: 20010003782
    Abstract: Certain novel sterol derivatives can be used for regulating the meiosis in oocytes and in male germ cells.
    Type: Application
    Filed: January 12, 2001
    Publication date: June 14, 2001
    Inventors: Peter Faarup, Frederick Christian Gronvald, Thorsten Blume, Anthony Murray, Jens Breinholt
  • Patent number: 5783575
    Abstract: The present invention relates to therapeutically active non competitive antagonists, acting selectively at the metabotropic glutamate receptor. The novel compounds are useful in treating diseases in the central nervous system by modulating synaptic transmission via the metabotropic glutamate receptor.
    Type: Grant
    Filed: July 31, 1995
    Date of Patent: July 21, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Palle Jakobsen, Anders Kanstrup, Peter Faarup, Preben H. Olesen, Jane Marie Lundbech
  • Patent number: 5646146
    Abstract: The present invention relates to 9H-indeno[1,2-b]pyrazin-3(4H)-ones and 9H-indeno[1,2-b]pyrazine-2,3(1H,4H)-diones or tautomeric forms thereof which are useful in treating neurological and psychiatric diseases based on the antagonism of the glycine binding site on the NMDA receptor complex.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: July 8, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Peter Faarup, Palle Jakobsen, Anker Steen J.o slashed.rgensen, Henrik Klitgaard
  • Patent number: 5536721
    Abstract: The present invention relates to therapeutically active heterocyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating diseases in the central nervous system related to the metabotropic glutamate receptor system.
    Type: Grant
    Filed: March 14, 1995
    Date of Patent: July 16, 1996
    Assignee: Novo Nordisk A/S
    Inventors: Palle Jakobsen, Anders Kanstrup, Peter Faarup, Preben H. Olesen
  • Patent number: RE39678
    Abstract: Certain novel sterol derivatives can be used for regulating the meiosis in oocytes and in male germ cells.
    Type: Grant
    Filed: June 17, 2004
    Date of Patent: June 5, 2007
    Assignees: Novo Nordisk A/S, Schering Aktiengesellschaft
    Inventors: Peter Faarup, Frederik Christian Grønvald, Thorsten Blume, Anthony Murray, Jens Breinholt